| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/28/2010 | CN101790524A 抗病毒化合物 Antiviral compounds |
| 07/28/2010 | CN101790522A Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 07/28/2010 | CN101790513A 1,3-dihydroisoindole derivatives |
| 07/28/2010 | CN101787019A Quinazoline derivatives |
| 07/28/2010 | CN101786997A Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide |
| 07/28/2010 | CN101786990A Compound having anti-itching activity |
| 07/27/2010 | US7763736 Contacting an organic azide and a terminal alkyne with a source of reactive Cu(I) ion for a time sufficient to form by cycloaddition a 1,4-disubstituted 1,2,3-triazole; high yields and high purity |
| 07/27/2010 | US7763644 Such as 1-(1H-imidazol-1-ylmethyl)pyrrolidin-2-one; levetiracetam (SV2 protein family) binding site ligands; anticonvulsant activity |
| 07/27/2010 | US7763631 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 07/27/2010 | US7763620 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 07/27/2010 | US7763617 Pyrazolopyridine-4-yl pyridazinone derivatives and addition salts thereof, and PDE inhibitors comprising the same derivatives or salts as active ingredient |
| 07/27/2010 | US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors |
| 07/27/2010 | US7763602 Drug resistant Mycobacterium tuberculosis |
| 07/27/2010 | US7763184 Benzotriazole compound other than 2-(2-hydroxy-3- alpha -cumyl-5-tert-octylphenyl)-2H-benzotriazole plus a hindered amine, a phosphite and a phenolic anti-oxidant compound; storage stability without using any volatile solvent |
| 07/27/2010 | CA2461060C Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 07/22/2010 | WO2010083501A2 Alpha-helix mimetic using a 2,5-oligopyrimidine scaffold |
| 07/22/2010 | WO2010083384A2 Non-peptidyl, potent, and selective mu opioid receptor antagonists |
| 07/22/2010 | WO2010083241A2 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |
| 07/22/2010 | WO2010083215A2 Composition and method for the treatment of diseases affected by apoptosis |
| 07/22/2010 | WO2010082044A1 Unsaturated bicyclic heterocyclic derivatives as smo antagonists |
| 07/22/2010 | WO2010081898A1 Novel benzotriazole derivatives useful for the treatment of cns disorders |
| 07/22/2010 | WO2010081835A2 Bis-resorcinyl-triazine derivatives as protecting agents against uv radiation |
| 07/22/2010 | WO2010081783A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/22/2010 | WO2010081387A1 N-substituted phenyl-3-methylene heterocyclic aryl-2,5-dimethylpyrrole compounds and anti-hiv/aids uses thereof |
| 07/22/2010 | WO2010056907A3 Heterocyclic compounds that induce pancreatic beta-cell expansion |
| 07/22/2010 | WO2010055082A3 New crystal form of sunitinib malate |
| 07/22/2010 | WO2010039518A3 Tricyclic carbamate jak inhibitors |
| 07/22/2010 | WO2010037059A3 Heteroaryl antagonists of prostaglandin d2 receptors |
| 07/22/2010 | WO2010036629A3 Fused multicyclic compounds as protein kinase inhibitors |
| 07/22/2010 | WO2010028259A3 9-aminonoscapine and its use in treating cancers, including drug- resistant cancers |
| 07/22/2010 | WO2010012745A3 Benzimidazoles |
| 07/22/2010 | WO2010007046A3 Heteroaryl derivatives as dgat1 inhibitors |
| 07/22/2010 | WO2009093127A3 Substantially pure and a stable crystalline form of bosentan |
| 07/22/2010 | US20100184991 Preparation of terazole derivatives |
| 07/22/2010 | US20100184981 2,3-dihydro-iminoisoindole derivatives |
| 07/22/2010 | US20100184978 Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex |
| 07/22/2010 | US20100184975 Compounds for alzheimber's disease |
| 07/22/2010 | US20100184814 Ester Derivatives of Losartan, Methods for Their Preparation, and Uses Thereof |
| 07/22/2010 | US20100184777 Substituted Pyrazinone Amides |
| 07/22/2010 | US20100184776 Piperidine/piperazine derivatives |
| 07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2010 | US20100184770 Compounds |
| 07/22/2010 | US20100184764 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/22/2010 | US20100184758 Beta carboline derivatives as antidiabetic compounds |
| 07/22/2010 | US20100184750 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | US20100184747 Indoline derivatives and their use in treating disease-states such as cancer |
| 07/22/2010 | US20100184741 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/22/2010 | US20100184737 Imidazole compounds for the treatment of neurological disorders |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183532 Performance-Boosting UV-Absorbing Compounds |
| 07/22/2010 | US20100183509 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof |
| 07/22/2010 | US20100181900 Carbazole compounds and organo-electroluminescent devices using the same |
| 07/22/2010 | CA2749157A1 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |
| 07/21/2010 | EP2208726A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 07/21/2010 | EP2208725A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/21/2010 | EP2207773A2 Heterocyclic compound and pharmaceutical composition thereof |
| 07/21/2010 | EP2207547A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 07/21/2010 | EP2099787B1 Aminopyrimidines useful as inhibitors of protein kinases |
| 07/21/2010 | EP1893573B1 Inhibitors of hcv replication |
| 07/21/2010 | EP1809622B1 Inhibitors of the interaction between mdm2 and p53 |
| 07/21/2010 | EP1613621B1 Prostaglandin analogs as ep4 receptor agonists |
| 07/21/2010 | EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 07/21/2010 | CN1960977B Quinazoline derivative |
| 07/21/2010 | CN1886389B Quinoxaline compounds |
| 07/21/2010 | CN101784545A Compounds useful as raf kinase inhibitors |
| 07/21/2010 | CN101784541A piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues |
| 07/21/2010 | CN101784540A alcohols containing imide moieties and reactive oligomers prepared therefrom |
| 07/21/2010 | CN101784532A Novel HIV reverse transcriptase inhibitors |
| 07/21/2010 | CN101784530A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 07/21/2010 | CN101784516A Dipeptide analogs as coagulation factor inhibitors |
| 07/21/2010 | CN101784276A Use of compounds for preparing anti-tuberculosis agents |
| 07/21/2010 | CN101781287A Irbesartan hydrobromide and preparation method thereof |
| 07/21/2010 | CN101781286A Method for preparing candesartan cilexetil |
| 07/21/2010 | CN101781265A Conjugate of amino acid and pesticide and preparation method thereof and application thereof as pesticide |
| 07/20/2010 | US7759499 used for the treatment or prevention of HCV or amelioration the symptoms of hepatitis C infection, by modulating the interaction of an HCV polypeptide with HCV proteases |
| 07/20/2010 | US7759388 Phenylalanine derivatives |
| 07/20/2010 | US7759385 opioid receptor ligands such as {4-[3-(1H-indol-3-yl)-pyrrolidine-1-yl]-1-phenyl-cyclohexyl}-dimethylamine dihydrochloride salt, used as analgesics |
| 07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
| 07/20/2010 | US7759373 nitrogen-containing 5-membered heterocyclic compound |
| 07/20/2010 | US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor |
| 07/20/2010 | US7759365 chemokines receptor modulators such as 4-(2-ethyl-6-fluoro-3-{1-[3-(4-fluoro-phenylsulfanyl)-propyl]-piperidin-4-yl}-indol-1-yl)-benzoic acid ethyl ester, used for treating inflammatory diseases such as asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 07/20/2010 | US7759363 Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists |
| 07/20/2010 | US7759357 N-[4-3-chloro-phenyl)-pyrimidin-2-yl]-N-(4-trifluoromethyl-phenyl)-amine, having immunoglobulin E (IgE) synthesis inhibiting activity, used for treating rheumatoid arthritis |
| 07/20/2010 | US7759352 Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulators |
| 07/20/2010 | US7759348 Pyridazine derivatives and their use as therapeutic agents |
| 07/20/2010 | US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 07/20/2010 | US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus |
| 07/20/2010 | US7759313 Induction method for cell differentiation |
| 07/20/2010 | US7758972 Stilbene derivative, light emitting element, light emitting device, and electronic appliance |
| 07/20/2010 | CA2539297C Substituted triazole derivatives as oxytocin antagonists |
| 07/20/2010 | CA2473954C Separation of acids from chemical reaction mixtures by means of ionic liquids |
| 07/20/2010 | CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 07/20/2010 | CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 07/20/2010 | CA2424454C Cyanine dyes |
| 07/20/2010 | CA2399001C Integrin expression inhibitor |
| 07/20/2010 | CA2290136C New erythromycin derivatives, the process for preparing them and their use as a drug product |
| 07/20/2010 | CA2282906C Stable complexes of poorly soluble compounds |
| 07/15/2010 | WO2010081036A2 Fluorine containing compounds and methods of use thereof |
| 07/15/2010 | WO2010081034A2 Fluorine containing compounds and methods of use thereof |
| 07/15/2010 | WO2010080817A2 Carbohydrate-cyclopamine conjugates as anticancer agents |